Neuhaus PJ |
Optimised first-line FK506-based protocols in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin. |
1994 |
Transplant. Proc. |
pmid:7527961
|
Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Morris R |
Modes of action of FK506, cyclosporin A, and rapamycin. |
1994 |
Transplant. Proc. |
pmid:7527964
|
Petuch BR et al. |
Microbial transformation of immunosuppressive compounds. III. Glucosylation of immunomycin (FR 900520) and FK 506 by Bacillus subtilis ATCC 55060. |
1994 |
J. Ind. Microbiol. |
pmid:7513528
|
Ericzon BG |
Early graft function in liver transplantation patients. |
1994 |
Transplant. Proc. |
pmid:7527965
|
Shaeffer MS et al. |
Interaction between FK506 and erythromycin. |
1994 |
Ann Pharmacother |
pmid:7513563
|
Ricordi C et al. |
Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. |
1994 |
Transplant. Proc. |
pmid:7527967
|
Lhöest GJ et al. |
15-Desmethyl FK-506 and 15,31-desmethyl FK-506 from human liver microsomes: isolation, identification (by fast atom bombardment mass spectrometry and NMR), and evaluation of in vitro immunosuppressive activity. |
1994 |
Clin. Chem. |
pmid:7513627
|
Ueda H et al. |
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. |
1994 |
J. Antibiot. |
pmid:7513682
|
Tai J et al. |
Effect of FK506 on rat Leydig cell function--in vivo and in vitro study. |
1994 |
Metab. Clin. Exp. |
pmid:7513780
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Burkhalter EL et al. |
Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. |
1994 |
J. Hepatol. |
pmid:7529272
|
Morozumi K and Takeda A |
[Kidney disorders induced by immunosuppressive agents]. |
1994 |
Nippon Naika Gakkai Zasshi |
pmid:7529294
|
Hashimoto T et al. |
Treatment with FK506 prevents rejection of rat colon allografts. |
1994 |
Transplantation |
pmid:7516586
|
Alamartine E et al. |
In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine, and prednisolone on lymphokine-activated killer cells. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7529381
|
Krentz AJ et al. |
Postoperative glucose metabolism in liver transplant recipients. A two-year prospective randomized study of cyclosporine versus FK506. |
1994 |
Transplantation |
pmid:7516590
|
Shapiro R et al. |
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. |
1994 |
Clin Transplant |
pmid:7532475
|
Ludwig B et al. |
Characterization of Mip proteins of Legionella pneumophila. |
1994 |
FEMS Microbiol. Lett. |
pmid:7516906
|
Atcherson MM and Trifillis AL |
Cytotoxic effects of FK506 on human renal proximal tubule cells in culture. |
1994 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:7529625
|
Murthy JN et al. |
Identification of a 14 kDa FK-506/rapamycin binding immunophilin from calf thymus. |
1994 |
Clin. Biochem. |
pmid:7532556
|
Maruyama K et al. |
FK 506 for vascular permeability factor production in minimal change nephrotic syndrome. |
1994 |
Nephron |
pmid:7517020
|
Donnelly JG and Soldin SJ |
Partial characterization of a 52 kDa CsA/FK506/rapamycin binding protein. |
1994 |
Clin. Biochem. |
pmid:7532557
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Peattie DA et al. |
Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12. |
1994 |
Gene |
pmid:7529739
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Dawson VL et al. |
Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. |
1994 |
Neuropharmacology |
pmid:7532825
|
Spada M et al. |
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518141
|
Spada M et al. |
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518142
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Okamoto M et al. |
Detection of allograft rejection in rat small bowel transplantation by analysing the in situ distribution of S-phase lymphocytes. |
1994 |
Transplant. Proc. |
pmid:7518145
|
Ippoliti G et al. |
Serum cytokine levels after small bowel transplantation in pigs. |
1994 |
Transplant. Proc. |
pmid:7518146
|
Orita T et al. |
Effect of FK 506 in combination with prednisolone on the graft-vs-host reaction after small bowel transplantation in rats. |
1994 |
Transplant. Proc. |
pmid:7518147
|
Yoshikawa N et al. |
Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice. |
1994 |
Clin. Endocrinol. (Oxf) |
pmid:7519528
|
Porayko MK et al. |
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. |
1994 |
Mayo Clin. Proc. |
pmid:7508536
|
Kao PN et al. |
Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. |
1994 |
J. Biol. Chem. |
pmid:7519613
|
Martin MF |
Nephrotoxic effects of immunosuppression. |
1994 |
Mayo Clin. Proc. |
pmid:7508537
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Okano K et al. |
Ameliorative effect of FK 506 on cold ischemia reperfusion injury of the rat liver. |
1994 |
Transplant. Proc. |
pmid:7520635
|
Connelly PR et al. |
Enthalpy of hydrogen bond formation in a protein-ligand binding reaction. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7510408
|
Kim YI et al. |
FK 506 prevents critical warm ischemia damage to the pig liver and improves hepatic microcirculation. |
1994 |
Transplant. Proc. |
pmid:7520636
|
Shiraga T et al. |
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. |
1994 |
Biochem. Pharmacol. |
pmid:7510480
|
Hirai T et al. |
A short course of FK506 can induce limited donor-specific graft acceptance. |
1994 |
Ann. Thorac. Surg. |
pmid:7520685
|
Kuwano K and Arai S |
The inhibitory effect of FK506 on cytotoxic T-lymphocyte killing. |
1994 |
Immunol. Lett. |
pmid:7536706
|
Hossain M et al. |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. |
1994 |
Arerugi |
pmid:7520689
|
Bell A et al. |
Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. |
1994 |
Biochem. Pharmacol. |
pmid:7520696
|
Paslaru L et al. |
GRP78 induction by cyclosporin A in human HeLa cells. |
1994 |
FEBS Lett. |
pmid:7520875
|
Gailliot FP et al. |
Isolation and characterization of the major equilibrium product of FK-520. |
1994 |
J. Antibiot. |
pmid:7520900
|
Okamoto S et al. |
The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. |
1994 |
J. Biol. Chem. |
pmid:7510691
|
Nakagawa H et al. |
Tacrolimus ointment for atopic dermatitis. |
1994 |
Lancet |
pmid:7522297
|
Sharkey J and Butcher SP |
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. |
1994 |
Nature |
pmid:7522303
|
Bram RJ and Crabtree GR |
Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. |
1994 |
Nature |
pmid:7522304
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Ueda K et al. |
Human P-glycoprotein as a multi-drug transporter analyzed by using transepithelial transport system. |
1994 |
Jpn. J. Physiol. |
pmid:7538609
|
|
FDA approved new drug bulletin: aprotinin injection (trasylol), tacrolimus (prograf). |
1994 |
RN |
pmid:7524131
|
Apanay DC et al. |
Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. |
1994 |
Transplantation |
pmid:7524202
|
Steinmüller TM et al. |
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. |
1994 |
Transplantation |
pmid:7524203
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Takahara S et al. |
Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7524219
|
Heitman J et al. |
Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition. |
1994 |
Transplant. Proc. |
pmid:7524220
|
Yoshimura R et al. |
Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat. |
1994 |
Transplant. Proc. |
pmid:7524223
|
Holländer GA et al. |
Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. |
1994 |
Transplantation |
pmid:7526495
|
Ishioka M et al. |
FK506 treatment of noninfectious uveitis. |
1994 |
Am. J. Ophthalmol. |
pmid:7526689
|
Carroll PB et al. |
Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. |
1994 |
Arch Dermatol |
pmid:7526802
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Mayrleitner M et al. |
The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. |
1994 |
Cell Calcium |
pmid:7511990
|
Bush KT et al. |
Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum. |
1994 |
Biochem. J. |
pmid:7526846
|
Kahan BD |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. |
1994 |
Ther Immunol |
pmid:7584478
|
Hamajima E et al. |
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats. |
1994 |
Dig. Dis. Sci. |
pmid:7512015
|
Akamine S et al. |
Monitoring canine lung allograft rejection using Ia antigen expression by bronchoalveolar lymphocytes. |
1994 |
Surg. Today |
pmid:7526914
|
Tsuchida M et al. |
The effects of FK506 and dexamethasone on rat thymocyte differentiation. |
1994 |
Ther Immunol |
pmid:7584489
|
Matsumoto T et al. |
Preventive effect of immunosuppressive agents against indomethacin-induced small intestinal ulcers in rats. |
1994 |
Dig. Dis. Sci. |
pmid:7512017
|
Lemoine A et al. |
FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantation. |
1994 |
Hepatology |
pmid:7527003
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Devlin J et al. |
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group. |
1994 |
Transpl. Int. |
pmid:11271328
|
Otto G et al. |
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271338
|
Wong P et al. |
FK 506 rescue therapy for intractable liver allograft rejection. |
1994 |
Transpl. Int. |
pmid:11271339
|
Mor E et al. |
Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. |
1994 |
Transpl. Int. |
pmid:11271340
|
Uemoto S et al. |
Long-term use of FK 506 in living related liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271341
|
Dmitrewski J et al. |
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin? |
1994 |
Transpl. Int. |
pmid:11271342
|
Assan R et al. |
FK 506/fluconazole interaction enhances FK 506 nephrotoxicity. |
1994 Jan-Feb |
Diabete Metab |
pmid:7520007
|
Perotti BY et al. |
FK 506 metabolism in male and female rat liver microsomes. |
1994 Jan-Feb |
Drug Metab. Dispos. |
pmid:7512020
|
Akita K et al. |
Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice. |
1994 Jan-Feb |
Cell Transplant |
pmid:7512875
|
Yasunami Y et al. |
Donor-specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: importance of low temperature culture and transplant site on induction and maintenance. |
1994 Jan-Feb |
Cell Transplant |
pmid:7512876
|
Yoshida Y et al. |
Comparison of cardiac rejection in heart and heart-lung concordant xenotransplantation. |
1994 Mar-Apr |
J. Heart Lung Transplant. |
pmid:7518252
|
Kay AB |
Immunosuppressive agents in chronic severe asthma. |
1994 May-Jun |
Allergy Proc |
pmid:7523242
|
von Asmuth EJ et al. |
IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. |
1994 May-Jun |
Eur. Cytokine Netw. |
pmid:7524716
|
Ryffel B et al. |
Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin. |
1994 Nov-Dec |
Exp. Nephrol. |
pmid:7532090
|
Cacciarelli TV et al. |
Influence of the timing of FK 506 (Tacrolimus) administration on recovery of renal function from warm ischemic injury in rats. |
1994 Oct-Dec |
ASAIO J. |
pmid:7532042
|
Karanam BV et al. |
FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4. |
1994 Sep-Oct |
Drug Metab. Dispos. |
pmid:7530623
|
Lionetti P et al. |
Mucosal adaptation and destruction in response to lamina propria T cell activation in explants of human fetal intestine. |
1995 |
Adv. Exp. Med. Biol. |
pmid:8525974
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Dumont FJ et al. |
Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. |
1995 |
Cell. Immunol. |
pmid:7538911
|